Trial Profile
A Phase I/II Study of T Cell Receptor Gene Therapy Targeting HPV-16 E6 for HPV-Associated Cancers
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs E6 TCR (Primary) ; Aldesleukin; Cyclophosphamide; Fludarabine
- Indications Anal cancer; Cancer; Cervical cancer; Oropharyngeal cancer; Penile cancer; Vulvovaginal cancer
- Focus Adverse reactions; First in man; Therapeutic Use
- 13 Aug 2019 Results published in the Journal of Clinical Oncology
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.